Kyverna Therapeutics Inc (KYTX) PT Raised to $25 at Morgan Stanley
Tweet
Share
E-mailGet Alerts KYTX Hot Sheet
Price: $8.95 +9.55%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Morgan Stanley analyst Michael Ulz raised the price target on Kyverna Therapeutics Inc (NASDAQ: KYTX) to $25.00 (from $20.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Info Edge India (INFOE:IN) PT Raised to INR1,260 at Macquarie
- Central Retail Corp PCL (CRC:TB) PT Lowered to THB9,000 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
